PAPER Watson E, Yu F
SEARCH RESULTS
329967 RESULTS
PAPER Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, González-Billault C, Núñez MT
Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
J Neurochem. 2013 Mar 19; PubMed: 23506423PAPER Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, Oneil A, Davey CG, Sanna L, Maes M
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness.
BMC Med. 2013 Mar 18;11(1):74. PubMed: 23506529PAPER Savelieff MG, Lee S, Liu Y, Lim MH
Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease.
ACS Chem Biol. 2013 May 17;8(5):856-65. PubMed: 23506614PAPER Martins I, Gomes S, Costa RO, Otvos L, Oliveira CR, Resende R, Pereira CM
Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers.
Neuroscience. 2013 Jun 25;241:41-51. PubMed: 23506735PAPER Thies W, Bleiler L,
2013 Alzheimer's disease facts and figures.
Alzheimers Dement. 2013 Mar;9(2):208-45. PubMed: 23507120PAPER Barroso E, Del Valle J, Porquet D, Vieira Santos AM, Salvadó L, Rodríguez-Rodríguez R, Gutiérrez P, Anglada-Huguet M, Alberch J, Camins A, Palomer X, Pallàs M, Michalik L, Wahli W, Vázquez-Carrera M
Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice.
Biochim Biophys Acta. 2013 Aug;1832(8):1241-8. PubMed: 23507144PAPER Du H, Guo L, Wu X, Sosunov AA, McKhann GM, Chen JX, Yan SS
Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.
Biochim Biophys Acta. 2013 Mar 16; PubMed: 23507145PAPER Bakkour A, Morris JC, Wolk DA, Dickerson BC
The effects of aging and Alzheimer's disease on cerebral cortical anatomy: Specificity and differential relationships with cognition.
Neuroimage. 2013 Aug 1;76:332-44. PubMed: 23507382PAPER Cho H, Seo SW, Kim JH, Suh MK, Lee JH, Choe YS, Lee KH, Kim JS, Kim GH, Noh Y, Ye BS, Kim HJ, Yoon CW, Chin J, Na DL
Amyloid Deposition in Early Onset versus Late Onset Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;35(4):813-21. PubMed: 23507771PAPER Kryscio RJ, Abner EL, Lin Y, Cooper GE, Fardo DW, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA
Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia.
J Alzheimers Dis. 2013 Jan 1;35(4):823-32. PubMed: 23507772PAPER Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S
Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;35(4):789-97. PubMed: 23507773PAPER Braak H, Feldengut S, Del Tredici K
[Pathogenesis and prevention of Alzheimer's disease: when and in what way does the pathological process begin?].
Nervenarzt. 2013 Apr;84(4):477-82. PubMed: 23508204PAPER Mulligan VK, Chakrabartty A
Protein misfolding in the late-onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis.
Proteins. 2013 Mar 18; PubMed: 23508986PAPER Calderón-Garcidueñas L, Franco-Lira M, Mora-Tiscareño A, Medina-Cortina H, Torres-Jardón R, Kavanaugh M
Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence.
Biomed Res Int. 2013;2013:161687. Epub 2013 Feb 7 PubMed: 23509683Current Filters
No filters selected